Omaxe Limited's Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting significant net losses.
The statutory auditors, BSD & Co., issued unmodified opinions on both sets of results but highlighted an ongoing SEBI appeal as an Emphasis of Matter.
Consolidated results show a net loss of ₹696.80 crore for FY26 and a basic EPS of -₹38.10, with a negative other equity of ₹1,084.42 crore.
The company disclosed proposed dividends from four subsidiaries and confirmed it does not qualify as a 'Large Corporate' for SEBI's debt issuance rules.